XPH — State Street SPDR S&P Pharmaceuticals ETF price, holdings and performance

State Street SPDR S&P Pharmaceuticals ETF

State Street SPDR S&P Pharmaceuticals ETF (AMEX: XPH) is an exchange-traded fund. QuoTrend tracks its price, holdings, performance, fund flows and news.

Latest market price
67.75
+0.96+1.44%
OverviewShort InterestFilings
XPHState Street SPDR S&P Pharmaceuticals ETF·AMEX
67.75+1.44%
TA
Loading chart...
Screen all →
VXUS+1.28%$86.50VUG+1.57%$88.43VTV+0.52%$221.78VO+0.77%$80.15VB+0.67%$290.91VWO+1.23%$59.91VGT+2.15%$121.48VIG+0.59%$237.12
Fund Snapshot
Category-Asset TypeEquityTagshealthcareReturn% 1Y47.51%Total Holdings63Perf Week-0.38%
SponsorSPDRETF TypeTagssectorReturn% 3Y17.90%AUM$591.91MPerf Month-6.49%
Fund FamilyBond TypeTags-Return% 5Y8.45%NAV/shPerf Quarter11.84%
Index-Average MaturityTags-Return% 10Y52W High74.35 -8.88%Perf Half Y27.66%
Index WeightingCommodity TypeTags-Return% SI52W Low45.82 47.86%Perf YTD20.96%
Active/PassiveQuant TypeTags-Flows% 1M0.00%Volatility1.69% 1.49%Perf Year47.31%
Dividend TTM0.34 (0.50%)ESG TypeTags-Flows% 3M0.00%ATR (14)1.29Perf 3Y56.50%
Dividend Ex-DateJun 22, 2026Dividend TypeSector/ThemeFlows% YTD2.43%RSI (14)41.14Perf 5Y40.27%
Dividend Gr. 3/5Y-Structure TypeRegionFlows% 1YBeta0.60Perf 10Y50.79%
Expense0.35%Growth/ValueSMA20-3.62%Flows% 3YRel Volume0.39Prev Close66.79
Inverse/LeveragedMarket CapSMA50-2.74%Flows% 5YAvg Volume133.92KPrice67.75
IPO DateJun 19, 2006Option/ShortYes / YesSMA20012.15%52W Range %77%Volume52,753Change1.44%
Assets Under Management
080.00M160.00M240.00M320.00MFebMayJulSepNov'25MarMayJulSepNov'26MarMayJulSep
● Assets Under Management
Latest News· Times ET
Sep-14-26
Sep-14-2612:25AM
Integrated Wealth Concepts LLC Buys Shares of 48,874 SPDR S&P Pharmaceuticals ETF $XPHdefenseworld.net
Sep-11-26
Sep-11-2605:29PM
IXJ vs XPH: Global Healthcare ETF or Pharma Focus?fool.com
Sep-10-26
Sep-10-2612:08PM
Better Healthcare ETF: Vanguard's VHT vs. State Street's Pharmaceuticals-Focused XPHfool.com
03:44AM
Which Healthcare ETF Is the Better Buy: Fidelity's Broad FHLC or State Street's Pharma-Focused XPH?fool.com
Sep-03-26
Sep-03-2608:05AM
The Market May Be Telling Us We're Entering A Capital Formation CycleSeekingAlpha
Aug-24-26
Aug-24-2606:55AM
Where Is Growth?SeekingAlpha
Aug-19-26
Aug-19-2605:10PM
Healthy And Energized At New HighsSeekingAlpha
Aug-17-26
Aug-17-2609:54AM
XPH vs PJP: Which Pharma ETF Offers Better Valuefool.com
Aug-12-26
Aug-12-2609:44AM
Better Healthcare ETF: State Street's Pharmaceuticals-Focused XPH vs. Invesco's S&P 500-Targeted RSPHfool.com
Aug-11-26
Aug-11-2608:30PM
Nearly A Third Of Tech Has Raised GuidanceSeekingAlpha
Aug-07-26
Aug-07-2603:21AM
Is State Street SPDR S&P Pharmaceuticals ETF (XPH) a Strong ETF Right Now?zacks.com
Aug-06-26
Aug-06-2609:20PM
Health Care Shakes Off A 5-Day SlideSeekingAlpha
03:21AM
Should You Invest in the State Street SPDR S&P Pharmaceuticals ETF (XPH)?zacks.com
Jul-30-26
Jul-30-2612:35AM
Some More Notes On Pharmaceutical TariffsSeekingAlpha
Jul-25-26
Jul-25-2604:25AM
Healthcare Systems' Liquidity ChallengeSeekingAlpha
Fund

SPDR Series Trust - SPDR S&P Pharmaceuticals ETF is an exchange traded fund launched by State Street Global Advisors, Inc. It is managed by SSGA Funds Management, Inc. It invests in public equity markets of the United States. The fund invests in stocks of companies operating across health care, pharmaceuticals, biotechnology and life sciences sectors. The fund invests in growth and value stocks of companies across diversified market capitalization. It seeks to track the performance of the S&P Pharmaceuticals Select Industry Index, by using representative sampling technique. SPDR Series Trust - SPDR S&P Pharmaceuticals ETF was formed on June 16, 2006 and is domiciled in the United States.

Ownership

Per-holder 13F data isn't yet ingested for ETFs — coming with the next data layer expansion. Aggregate ownership shown above.

open in yahoo·open in reuters·open in marketwatch·open in google·open in EDGAR